Back to
Brown Advisory Inc.
STLN
5 quarters
Position history for
Brown Advisory Inc.'s holdings in Starling Oncology, Inc.
No. Brown Advisory exited its STLN (Starling Oncology) position in Q2 2024. Its Q1 2024 13F listed 18,674 shares worth $29,505. Brown Advisory first reported STLN in Q2 2023 and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$10,274
Total Shares Change
-18,674
Quarter-by-Quarter History
Other major holders of STLN: FMR LLC, BlackRock, Inc.